Top compounds associated with response to TIGD2


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.08
mRNA Merck60 CTRPv2 pan-cancer AAC 0.053 0.08
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.058 0.08
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA thalidomide CTRPv2 pan-cancer AAC 0.096 0.08
mRNA brivanib CTRPv2 pan-cancer AAC 0.063 0.08
mRNA KIN001-135 GDSC1000 pan-cancer AAC -0.092 0.09
mRNA GSK-1904529A GDSC1000 pan-cancer AAC 0.058 0.09
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.065 0.09
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.075 0.09
Download CSV